Table 1 Titers of PR3-ANCA and MPO-ANCA in serum from WG patients, polyarteritis nodosa patients, and aortitis syndrome patients used in this study.
No. (sample code) (bleeding date) | PR3-ANCA (U/ml) | MPO-ANCA (U/ml) |
|---|---|---|
1. (Q9-40) (5/9/1996) | 29.2 | < 1.3 |
(R9-10) (9/27/1996) | 19.1 | < 1.3 |
(S9-31) (11/21/1996) | 10.7 | < 1.3 |
2. (R9-7) (9/27/1996) | 3.8 | < 1.3 |
(S9-29) (11/19/1996) | 3.5 | < 1.3 |
3. (S9-32) (11/21/1996) | 18.8 | < 1.3 |
4. (D10-41) (4/4/2000) | 14.0 | < 1.3 |
5. (M10-24) (2/3/2004) | < 1.3 | < 1.3 |
6. (M10-28) (2/3/2004) | < 1.3 | < 1.3 |
7. (G10-37) (5/15/2002) | < 1.3 | < 1.3 |
8. (H10-51) (9/2/2002) | < 1.3 | < 1.3 |